CLINICAL_TRIALS
withdrawal
· 2026-02-11
Clinical Trial Update: The Use of Isocapnic Hyperventilation (iHV) for Treatment of Methanol Poisoned Patients [Phase 1]
Summary
A Phase 1 clinical trial evaluating isocapnic hyperventilation for methanol poisoning was withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Oslo University Hospital | Conditions: Methanol Poisoning | Phase 1 | Status: WITHDRAWN